The site of absorption has been reported to be the stomach ( Although there are GLP-1 receptors in the stomach wall, these appear to be mechanoreceptors, and control local motility of the gastric tissue, rather than being involved in direct messaging to the brain ( The Axcess formulation was originally developed by Diabetology in 2003, and recent improvements have increased efficacy further, increasing the scope of the associated intellectual property, and providing cover out to 2040 and beyond
Patients should be educated about symptom recognition and encouraged to report any concerning abdominal symptoms promptly
These drugs commonly lead to gastrointestinal issues, nausea often reported as a primary concern
However, during pregnancy, your body produces 80% MORE of the toxic NAPQI metabolite (43% higher in first trimester), sulfation capacity decreases 33%, and glutathione depletes 36-87%
Frequently Asked Questions What does GLP-3 stand for
The more honest comparison is opportunity cost